1. The use of blood pressure-1-phosphoric acid (SGP) inhibitors made from aminoacrylonitrile derivatives to treat cerebral malaria; pharmacological formulations and pharmacological forms, including SGP potentiators and antipanic drugs.

摘要

Use of monoamines in the treatment of cerebral malaria, S1P receptor agonists, Pharmaceutical composition that comprises.